Jeffrey S. Stonebraker PhD.

Jeffrey S. Stonebraker is an associate professor at North Carolina State University’s Poole College of Management with research and teaching interests in decision analysis and forecasting long-range global demand for hemophilia and other rare diseases. Prior to this, he was a decision analyst with Bayer Biological Products and GlaxoSmithKline. Jeff is a retired US Air… Continue reading Jeffrey S. Stonebraker PhD.

David Page

David Page is currently National Executive Director of the Canadian Hemophilia Society (CHS). He served as a volunteer with the CHS from 1982 to 2001, including a 2-year term as President in the 1990s. In 2001, he left the field of teaching and educational publishing to take a staff position with the CHS. Before becoming… Continue reading David Page

Brian O’Mahony

Brian O’Mahony is the Chief Executive of the Irish Haemophilia Society and the President of the European Haemophilia Consortium. He represents the society on the statutory National Haemophilia Council and he is the Vice Chair of the Tender Commission established by the Irish Government for the Procurement of Factor Concentrates. He is a member of… Continue reading Brian O’Mahony

Declan Noone

Declan Noone worked with the Irish Haemophilia Society (IHS) for the last 8 years as Data and Public Policy Specialist.  The main responsibilities in involved membership of the National tender board for the purchase of products for the treatment of haemophilia and other related conditions. He also worked on the area of Hepatitis C and… Continue reading Declan Noone

Michael B. Nichol PhD.

Dr. Nichol serves as Professor of Health Policy at the University of Southern California’s Sol Price School of Public Policy. In addition, he is Price’s Vice Dean for Faculty Affairs and directs the school’s Graduate Health Programs. These programs include the Master in Health Administration and the Executive Master in Health Administration. Dr. Nichol is… Continue reading Michael B. Nichol PhD.

Neil Frick MS

Neil Frick has a Master of Science, 1993, St. John’s University, Jamaica, NY, Rehabilitation Counseling. He is responsible for the overall strategic and operational leadership of the National Hemophilia Foundation’s (NHF) research programs and HANDI Information Resource Center including oversight of the processes of material development, update and distribution channels. Supervise the awarding of NHF… Continue reading Neil Frick MS

Randall G. Curtis MBA

Randall Curtis has a bachelor of science in genetics and an MBA in computer information systems. He is also a certified Project Management Professional (PMP) by the Project Management Institute and a Microsoft Certified Systems Engineer. Throughout his 33 year career with the State of California in Public Health and Industrial Relations, he as always… Continue reading Randall G. Curtis MBA

Chatree Chai-Adiskaksopha MD

Chatree is a clinical hematologist. After he completed medical degree, Internal Medicine and Hematology from Thailand, he completed a fellowship training in thrombosis and haemostasis at McMaster University, Canada. His PhD thesis was focusing on the patient reported outcomes development and validation. His research interest includes thrombosis and haemostasis, patient reported outcomes, systematic review and… Continue reading Chatree Chai-Adiskaksopha MD

Mark W. Skinner JD

Mark Skinner, Washington, DC, is President/CEO of the Institute for Policy Advancement, Ltd., a global health strategies consulting company specializing in patient-centered healthcare and outcomes research, and a Senior Consultant to the Workers Compensation Research Institute. He has led both national and international patient organizations, including the World Federation of Hemophilia and National Hemophilia Foundation,… Continue reading Mark W. Skinner JD